{"id":238526,"date":"2026-09-09T15:27:40","date_gmt":"2026-09-09T09:57:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=238526"},"modified":"2026-11-16T15:18:15","modified_gmt":"2026-11-16T09:48:15","slug":"why-gujarat-themis-biosyn-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/","title":{"rendered":"Gujarat Themis Biosyn (GUJTHEM) Share Price Falls 7.71% to Rs 359.25 Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM)<\/a> share price fell to Rs 359.25 today, down 7.71% from the previous close. Market cap was Rs 5,066.16 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">The <strong>Gujarat Themis Biosyn share price<\/strong> fell 7.71% on 16 November 2026, with the stock last trading at Rs 359.25 against the previous close of Rs 389.25, a fall of Rs 30 per share. At this level, Gujarat Themis Biosyn (GUJTHEM) carries a market capitalisation of Rs 5,066.16 crore and sits in the Mid Cap category, according to Univest data as of 16 November 2026 at 3:07:51 PM IST.<\/p>\n<p>This Gujarat Themis Biosyn share price fall is the main market event for the stock today. The stock opened at Rs 377.70, touched a high of Rs 379.00 and a low of Rs 357.40, so the whole day range sits below the previous close. The sections below cover Gujarat Themis Biosyn share price today in detail, followed by the context around the move, valuation multiples, sector and peer comparison, and what investors can monitor next.<\/p>\n<p>The Gujarat Themis Biosyn stock analysis shows a P\/E ratio of 118.13 and a P\/B ratio of 4.83, with ROE of 17.41% and ROCE of 18.16%. These figures frame the Gujarat Themis Biosyn share price update that follows.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis\">Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Why_Gujarat_Themis_Biosyn_GUJTHEM_May_Be_Moving_Today\" title=\"Why Gujarat Themis Biosyn (GUJTHEM) May Be Moving Today\">Why Gujarat Themis Biosyn (GUJTHEM) May Be Moving Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis\">Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\" title=\"Why Investors Are Watching Gujarat Themis Biosyn\">Why Investors Are Watching Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#About_Gujarat_Themis_Biosyn\" title=\"About Gujarat Themis Biosyn\">About Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\" title=\"Track Gujarat Themis Biosyn Share Price on Univest\">Track Gujarat Themis Biosyn Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_is_the_Gujarat_Themis_Biosyn_share_price_today\" title=\"What is the Gujarat Themis Biosyn share price today?\">What is the Gujarat Themis Biosyn share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#How_much_has_the_Gujarat_Themis_Biosyn_share_price_fallen_today\" title=\"How much has the Gujarat Themis Biosyn share price fallen today?\">How much has the Gujarat Themis Biosyn share price fallen today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_is_the_market_capitalisation_of_Gujarat_Themis_Biosyn\" title=\"What is the market capitalisation of Gujarat Themis Biosyn?\">What is the market capitalisation of Gujarat Themis Biosyn?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_is_the_PE_ratio_of_Gujarat_Themis_Biosyn\" title=\"What is the P\/E ratio of Gujarat Themis Biosyn?\">What is the P\/E ratio of Gujarat Themis Biosyn?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_are_the_ROE_and_ROCE_of_Gujarat_Themis_Biosyn\" title=\"What are the ROE and ROCE of Gujarat Themis Biosyn?\">What are the ROE and ROCE of Gujarat Themis Biosyn?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_are_the_EPS_and_book_value_of_Gujarat_Themis_Biosyn\" title=\"What are the EPS and book value of Gujarat Themis Biosyn?\">What are the EPS and book value of Gujarat Themis Biosyn?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#How_does_Gujarat_Themis_Biosyn_compare_with_its_peers\" title=\"How does Gujarat Themis Biosyn compare with its peers?\">How does Gujarat Themis Biosyn compare with its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#Which_sector_and_industry_does_Gujarat_Themis_Biosyn_belong_to\" title=\"Which sector and industry does Gujarat Themis Biosyn belong to?\">Which sector and industry does Gujarat Themis Biosyn belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-fall-today-2026\/#What_can_investors_monitor_next_for_the_Gujarat_Themis_Biosyn_share_price\" title=\"What can investors monitor next for the Gujarat Themis Biosyn share price?\">What can investors monitor next for the Gujarat Themis Biosyn share price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 359.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 389.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 30.00 (-7.71%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 377.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 379<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 357.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,066.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The Gujarat Themis Biosyn share price today stands at Rs 359.25, which is 7.71% below the previous close of Rs 389.25. The stock has lost Rs 30 per share, and its Rs 5,066.16 crore market capitalisation places it in the Mid Cap category. These figures are as of 16 November 2026 at 3:07:51 PM IST.<\/p>\n<p>Looking at the day range, the Gujarat Themis Biosyn stock opened at Rs 377.70, which was already Rs 11.55 below the previous close. The day high of Rs 379.00 was only Rs 1.30 above the opening level, and the day low of Rs 357.40 is just Rs 1.85 below the current price. In other words, the Gujarat Themis Biosyn share price is trading close to the bottom of its range for the day, so the fall shows up in the percentage move and in the range itself. The next sections place this price action alongside the company&#8217;s reported context, fundamentals, valuation and peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Gujarat_Themis_Biosyn_GUJTHEM_May_Be_Moving_Today\"><\/span><strong>Why Gujarat Themis Biosyn (GUJTHEM) May Be Moving Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"news-context\">According to recent news reports, three second-quarter updates were published on 14 Nov at 3:28 pm IST and may be connected to today&#8217;s move in the Gujarat Themis Biosyn share price. EBITDA was reported at 177 million rupees against 209 million rupees a year earlier, with the EBITDA margin at 37.33% compared with 49.46%. Net profit was reported at 85 million rupees, down from 143 million rupees in the same period last year, while revenue rose to 474.5 million rupees from 423 million rupees. The mix of higher revenue with lower EBITDA, margin and net profit could be linked to the reaction in the stock, but the market data itself does not establish a single confirmed cause for the decline.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,066.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">118.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 80.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.17%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn (GUJTHEM) fundamental metrics show P\/E 118.13x, P\/B 4.83x, ROE 17.41%, ROCE 18.16%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Gujarat Themis Biosyn has a market capitalisation of Rs 5,066.16 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 118.13x, P\/B at 4.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.41% and ROCE of 18.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.3, book value per share of Rs 80.59, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">118.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">52.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.6x to 1,177x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.14%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,066.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 698.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,540.61 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn (GUJTHEM) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Gujarat Themis Biosyn (GUJTHEM) has a P\/E ratio of 118.13x, which is above the benchmark median of 30.93x, a difference of +281.93%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Gujarat Themis Biosyn (GUJTHEM) has a ROE of 17.41%, which is above the benchmark median of 10.98%, a difference of +58.56%. Gujarat Themis Biosyn (GUJTHEM) has a ROCE of 18.16%, which is above the benchmark median of 12.63%, a difference of +43.78%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,51,290.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,05,014.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">90.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,77,333.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,30,755.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">97.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,802.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn (GUJTHEM) has a P\/E ratio of 118.13x compared with the displayed peer median of 83.49x. The comparison is relative and should not be read as a recommendation. Its ROE of 17.41% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 18.16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gujarat Themis Biosyn (GUJTHEM) has a market capitalisation of Rs 5,066.16 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\"><\/span><strong>Why Investors Are Watching Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The Gujarat Themis Biosyn share price today is Rs 359.25, down 7.71% from the previous close of Rs 389.25.<\/li>\n<li>The day range runs from a low of Rs 357.40 to a high of Rs 379.00.<\/li>\n<li>The P\/E ratio of 118.13 and P\/B ratio of 4.83 are above the industry medians of 30.93 and 2.9.<\/li>\n<li>ROE of 17.41% and ROCE of 18.16% are above the industry medians of 10.98% and 12.63%.<\/li>\n<li>Market capitalisation of Rs 5,066.16 crore places the company in the Mid Cap category.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Gujarat_Themis_Biosyn\"><\/span><strong>About Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gujarat Themis Biosyn trades under the symbol GUJTHEM and operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry. According to Univest data, the company is classified as a Mid Cap business with a market capitalisation of Rs 5,066.16 crore. The Pharmaceuticals &amp; Drugs benchmark spans 205 companies, from very small listed firms to large pharmaceutical majors such as Sun Pharmaceutical Industries and Divi&#8217;s Laboratories. Within that group, Gujarat Themis Biosyn is above the industry median market capitalisation, with its ROE and ROCE also above the industry medians.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\"><\/span><strong>Track Gujarat Themis Biosyn Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can track the Gujarat Themis Biosyn share price live on Univest, along with fundamental ratios such as P\/E, P\/B, ROE and ROCE, 52-week levels and wider market insights. The stock page keeps the Gujarat Themis Biosyn share price update, company financials and sector benchmarks together, which makes it easier to follow how the stock compares with peers over time. Reading the Gujarat Themis Biosyn share price alongside these ratios gives a fuller picture than the daily percentage move alone.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Gujarat_Themis_Biosyn_share_price_today\"><\/span><strong>What is the Gujarat Themis Biosyn share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The Gujarat Themis Biosyn share price today is Rs 359.25 as of 16 November 2026 at 3:07:51 PM IST. That is 7.71% below the previous close of Rs 389.25, a fall of Rs 30 per share on the day.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_has_the_Gujarat_Themis_Biosyn_share_price_fallen_today\"><\/span><strong>How much has the Gujarat Themis Biosyn share price fallen today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock has fallen 7.71%, or Rs 30 per share, from the previous close of Rs 389.25. It opened at Rs 377.70, touched a high of Rs 379.00 and a low of Rs 357.40 during the day so far.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Gujarat_Themis_Biosyn\"><\/span><strong>What is the market capitalisation of Gujarat Themis Biosyn?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Gujarat Themis Biosyn has a market capitalisation of Rs 5,066.16 crore and sits in the Mid Cap category. That is above the Pharmaceuticals &amp; Drugs industry median market capitalisation of Rs 698.04 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Gujarat_Themis_Biosyn\"><\/span><strong>What is the P\/E ratio of Gujarat Themis Biosyn?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The P\/E ratio is 118.13, compared with an industry median of 30.93 and an industry average of 52.22 across 171 companies with P\/E data. The P\/B ratio is 4.83 against an industry median of 2.9.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_of_Gujarat_Themis_Biosyn\"><\/span><strong>What are the ROE and ROCE of Gujarat Themis Biosyn?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;ROE is 17.41% and ROCE is 18.16%. Both sit above the industry medians of 10.98% and 12.63%, although the ROCE figure is lower than each of the five peers shown in the peer comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_EPS_and_book_value_of_Gujarat_Themis_Biosyn\"><\/span><strong>What are the EPS and book value of Gujarat Themis Biosyn?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;EPS is Rs 3.30 and book value per share is Rs 80.59. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The dividend yield is 0.17%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Gujarat_Themis_Biosyn_compare_with_its_peers\"><\/span><strong>How does Gujarat Themis Biosyn compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Its P\/E of 118.13 is higher than Sun Pharma at 41.15, Zydus Lifesciences at 28.42, Torrent at 83.49, Divi&#39;s Laboratories at 90.70 and Laurus Labs at 97.59. Its market capitalisation is also smaller than all five.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_and_industry_does_Gujarat_Themis_Biosyn_belong_to\"><\/span><strong>Which sector and industry does Gujarat Themis Biosyn belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Gujarat Themis Biosyn belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. Univest benchmarks it against 205 companies in the same industry when comparing valuation, ROE, ROCE and market capitalisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_can_investors_monitor_next_for_the_Gujarat_Themis_Biosyn_share_price\"><\/span><strong>What can investors monitor next for the Gujarat Themis Biosyn share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors can monitor the day range between Rs 357.40 and Rs 379.00, the P\/E ratio of 118.13 against the industry median of 30.93, and the ROE and ROCE figures against peers. This is information, not a recommendation.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Gujarat Themis Biosyn share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Gujarat Themis Biosyn share price today is Rs 359.25 as of 16 November 2026 at 3:07:51 PM IST. That is 7.71% below the previous close of Rs 389.25, a fall of Rs 30 per share on the day.\"}},{\"@type\":\"Question\",\"name\":\"How much has the Gujarat Themis Biosyn share price fallen today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock has fallen 7.71%, or Rs 30 per share, from the previous close of Rs 389.25. It opened at Rs 377.70, touched a high of Rs 379.00 and a low of Rs 357.40 during the day so far.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of Gujarat Themis Biosyn?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gujarat Themis Biosyn has a market capitalisation of Rs 5,066.16 crore and sits in the Mid Cap category. That is above the Pharmaceuticals & Drugs industry median market capitalisation of Rs 698.04 crore.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Gujarat Themis Biosyn?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 118.13, compared with an industry median of 30.93 and an industry average of 52.22 across 171 companies with P\/E data. The P\/B ratio is 4.83 against an industry median of 2.9.\"}},{\"@type\":\"Question\",\"name\":\"What are the ROE and ROCE of Gujarat Themis Biosyn?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ROE is 17.41% and ROCE is 18.16%. Both sit above the industry medians of 10.98% and 12.63%, although the ROCE figure is lower than each of the five peers shown in the peer comparison.\"}},{\"@type\":\"Question\",\"name\":\"What are the EPS and book value of Gujarat Themis Biosyn?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"EPS is Rs 3.30 and book value per share is Rs 80.59. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The dividend yield is 0.17%.\"}},{\"@type\":\"Question\",\"name\":\"How does Gujarat Themis Biosyn compare with its peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E of 118.13 is higher than Sun Pharma at 41.15, Zydus Lifesciences at 28.42, Torrent at 83.49, Divi's Laboratories at 90.70 and Laurus Labs at 97.59. Its market capitalisation is also smaller than all five.\"}},{\"@type\":\"Question\",\"name\":\"Which sector and industry does Gujarat Themis Biosyn belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gujarat Themis Biosyn belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Univest benchmarks it against 205 companies in the same industry when comparing valuation, ROE, ROCE and market capitalisation.\"}},{\"@type\":\"Question\",\"name\":\"What can investors monitor next for the Gujarat Themis Biosyn share price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can monitor the day range between Rs 357.40 and Rs 379.00, the P\/E ratio of 118.13 against the industry median of 30.93, and the ROE and ROCE figures against peers. This is information, not a recommendation.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Gujarat Themis Biosyn Share Price fell 7.71% to Rs 359.25 today. Market cap stands at Rs 5,066.16 crore.<\/p>\n","protected":false},"author":35,"featured_media":348949,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-238526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348949"],"rank_math_title":["Gujarat Themis Biosyn Share Price Today: Price Fall Analysis"],"rank_math_description":["Gujarat Themis Biosyn share price fell 7.71% to Rs 359.25 from Rs 389.25. See price action, P\/E, ROE, ROCE, sector and peer analysis on Univest today."],"rank_math_focus_keyword":["Gujarat Themis Biosyn Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Falls_771_to_Rs_35925_Today_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=238526"}],"version-history":[{"count":3,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526\/revisions"}],"predecessor-version":[{"id":348951,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238526\/revisions\/348951"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348949"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=238526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=238526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=238526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}